ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests

May 31, 1974

Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49

April 4, 1997

USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening

September 28, 2012

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

HHS News: Skin Cancer Awareness Initiative Begun

May 29, 1998

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994